Shanghai Wingsung Investment Management Co., Ltd. is principally engaged in pharmaceutical production and distribution. the Company's major products include bacitracin ointment, glucose injections and cantharidate injections, among others. The Company distributes its products primarily in domestic market. As of December 31, 2009, the Company had one subsidiary, which involved in pharmaceutical production and distribution. During the year ended December 31, 2009, the Company changed its named from Shanghai Wingsung Data Technology Co., Ltd. to Shanghai Wingsung Investment Management Co., Ltd.